Tyler Jacks, Ph.D.

Dr. Tyler Jacks serves as a Director at Thermo Fisher Scientific, based in Waltham, MA, with a tenure of 14 years in his current role. Jacks also served on the Board of Directors at Amgen Inc. and in various leadership positions at Dragonfly Therapeutics and Skyhawk Therapeutics.

Dr. Jacks is actively involved in non-profit organizations, including serving as the President of Break Through Cancer, Professor of Biology at Massachusetts Institute of Technology, The Lustgarten Foundation, Harvard University, and previously at Howard Hughes Medical Institute, The Medical Foundation, and Cancer Prevention and Research Institute of Texas. Additionally, he is recognized for his political affiliations as the Co-Chair of the Blue-Ribbon Panel for Vice President Joe Biden at the National Cancer Institute.

He holds a Bachelor’s Degree in Biology from Harvard University and a Ph.D. from the University of California San Francisco. He has not made any recorded political contributions to the Republican party and has contributed $4,500 to the Democrat party.